Source:http://linkedlifedata.com/resource/pubmed/id/11589197
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
36
|
pubmed:dateCreated |
2001-10-6
|
pubmed:language |
dut
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Sep
|
pubmed:issn |
0028-2162
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:day |
8
|
pubmed:volume |
145
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
1766-7
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:11589197-Antineoplastic Agents, Hormonal,
pubmed-meshheading:11589197-Breast Neoplasms,
pubmed-meshheading:11589197-Female,
pubmed-meshheading:11589197-Humans,
pubmed-meshheading:11589197-Netherlands,
pubmed-meshheading:11589197-Ovarian Cysts,
pubmed-meshheading:11589197-Practice Guidelines as Topic,
pubmed-meshheading:11589197-Premenopause,
pubmed-meshheading:11589197-Tamoxifen
|
pubmed:year |
2001
|
pubmed:articleTitle |
[Tamoxifen; wider indications, more frequent controls?].
|
pubmed:publicationType |
Letter
|